Insider Transactions in Q2 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
531
-3.22%
|
$10,620
$20.25 P/Share
|
|
Apr 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,929
+10.47%
|
-
|
|
Apr 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-4.01%
|
$11,480
$20.25 P/Share
|
|
Apr 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,607
+10.08%
|
-
|
|
Apr 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-1.43%
|
$10,540
$20.25 P/Share
|
|
Apr 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,340
+3.51%
|
-
|